Baseball pitching has been described as an anaerobic activity from a bioenergetics standpoint with short bouts of recovery. Depending on the physical conditioning and muscle fiber composition of the pitcher as well as the number of pitches thrown per inning and per game, there is the possibility of pitchers fatiguing during a game, which could lead to a decrease in pitching performance. Therefore, the purpose of this study was to evaluate the effects of 3 recovery protocols: passive recovery, active recovery (AR), and electrical muscle stimulation (EMS) on range of motion (ROM), heart rate (HR), rating of perceived exertion (RPE), and blood lactate concentration in baseball pitchers during a simulated game. Twenty-one Division I intercollegiate baseball pitchers (age = 20.4 ± 1.4 years; height = 185.9 ± 8.4 cm; weight = 86.5 ± 8.9 kg; percent body fat = 11.2 ± 2.6) volunteered to pitch 3 simulated 5-inning games, with a maximum of 70 fastballs thrown per game while wearing an HR monitor. Range of motion was measured pre, post, and 24 hours postpitching for shoulder internal and external rotation at 90° and elbow flexion and extension. Heart rate was recorded after each pitch and after every 30 seconds of the 6-minute recovery period. Rating of perceived exertion was recorded after the last pitch of each inning and after completing each 6-minute recovery period. Immediately after throwing the last pitch of each inning, postpitching blood lactate concentration (PPLa-) was measured. At the end of the 6-minute recovery period, before the next inning started, postrecovery blood lactate concentration (PRLa-) was measured. Pitchers were instructed to throw each pitch at or above 95% of their best-pitched fastball. This was enforced to ensure that each pitcher was throwing close to maximal effort for all 3 simulated games. All data presented represent group mean values. Results revealed that the method of recovery protocol did not significantly influence ROM (p > 0.05); however, it did significantly influence blood lactate concentration (p < 0.001), HR (p < 0.001), and RPE (p = 0.01). Blood lactate concentration significantly decreased from postpitching to postrecovery in the EMS recovery condition (p < 0.001), but did not change for either the active (p = 0.04) or the passive (p = 0.684) recovery conditions. Rating of perceived exertion decreased from the postpitching to postrecovery in both the passive and EMS recovery methods (p < 0.001), but did not decrease for AR (p = 0.067). Heart rate decreased for all conditions from postpitching to postrecovery (p < 0.001). The use of EMS was the most effective method at reducing blood lactate concentration after 6 minutes of recovery during a simulated game (controlled setting). Although EMS significantly reduced blood lactate concentrations after recovery, blood lactate concentrations after pitching in the simulated games were never high enough to cause skeletal muscle fatigue and decrease pitching velocity. If a pitcher were to throw more than 14 pitches per inning, throw more total pitches than normal per game, and have blood lactate concentrations increase higher than in the simulated games in this study, the EMS recovery protocol may be beneficial to pitching performance by aiding recovery. This could potentially reduce some injuries associated with skeletal muscle fatigue during pitching, may allow a pitcher throw more pitches per game, and may reduce the number of days between pitching appearances.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1519/JSC.0000000000000487 | DOI Listing |
Curr Med Chem
January 2025
Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva, 384012, India.
Aims: This study aimed to develop Imatinib Mesylate (IMT)-loaded Poly Lactic-co-Glycolic Acid (PLGA)-D-α-tocopheryl polyethylene glycol succinate (TPGS)- Polyethylene glycol (PEG) hybrid nanoparticles (CSLHNPs) with optimized physicochemical properties for targeted delivery to glioblastoma multiforme.
Background: Glioblastoma multiforme (GBM) is the most destructive type of brain tumor with several complications. Currently, most treatments for drug delivery for this disease face challenges due to the poor blood-brain barrier (BBB) and lack of site-specific delivery.
World J Diabetes
January 2025
Department of Nephrology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China.
Background: Mizagliflozin (MIZ) is a specific inhibitor of sodium-glucose cotransport protein 1 (SGLT1) originally developed as a medication for diabetes.
Aim: To explore the impact of MIZ on diabetic nephropathy (DN).
Methods: Diabetic mice were created using db/db mice.
ACS Pharmacol Transl Sci
January 2025
Pharmaceutical Institute, Pharmacology and Toxicology, University of Bonn, Gerhard-Domagk-Str. 3, 53121 Bonn, Germany.
Lipopolysaccharide (LPS)-neutralizing peptides are emerging as new potential therapeutic modalities to treat sepsis and skin infections. Purinergic ligand-gated ion channels (P2X receptors) play a critical role in various biological processes, including inflammation. Recent drug development efforts have significantly focused on the modulation of P2X receptors.
View Article and Find Full Text PDFTransl Cancer Res
December 2024
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Background: Currently, traditional blood biomarkers such as neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCA) etc. are mostly elevated in the late stage of tumour, and patients have already lost the chance of tumour eradication when the relevant indexes are found to be elevated. Therefore, there is a need for blood biomarkers with higher sensitivity, better specificity, and better accessibility.
View Article and Find Full Text PDFNarra J
December 2024
Department of Animal Production and Technology, Faculty of Animal Science, Institut Pertanian Bogor, Bogor, Indonesia.
Previous studies of IIA-1A5 have shown its potential as a probiotic in modulating gut microbiota and providing health benefits; however, its effects during pregnancy remain underexplored. The aim of this study was to assess the safety of fermented milk enriched with IIA-IA5 in pregnant mice. An experimental study was conducted at Universitas Andalas, Padang, Indonesia.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!